Synairgen (LON:SNG) Shares Pass Below 200 Day Moving Average of $5.17

Synairgen plc (LON:SNG) shares crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 5.17 ($0.07) and traded as low as GBX 3.31 ($0.04). Synairgen shares last traded at GBX 3.50 ($0.05), with a volume of 580,768 shares changing hands.

Synairgen Stock Up 12.6 %

The firm has a market cap of £7.94 million, a PE ratio of -87.50 and a beta of -2.23. The company has a debt-to-equity ratio of 0.09, a quick ratio of 6.35 and a current ratio of 6.77. The company’s 50-day simple moving average is GBX 3.96 and its two-hundred day simple moving average is GBX 5.17.

Synairgen Company Profile

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.